top of page

Investor & News

Share Information:

ROS Therapeutics ApS is a privately held company, operating under the CVR number 39507501


Stock Information:

Number of shares:  81,565
Nominal value per share:  DKK 1                                                                                     

Share capital:  DKK 81,565  


Shareholders holding more than 5% of the shares:

ROS Therapeutics Holding ApS


Rasmus Wilhelmsen


Principal Law Firm:

Bach Advokater / Ricki Boye


Key dates:

Founded:                                                                        23rd of April, 2018

Most recent capital increase:                                      12th of July, 2018

Most recent Annual General Meeting:                       Not applicable

Financial Calendar year-end:                                       31 December


A New targeted MTX underway for RA


Health Europa Quarterly (issue 07) highlights the advantages and disadvantages of the currently recommended first-line treatment for rheumatoid arthritis and reflects on recent research into a possible alternative: A new targeted-MTX treatment underway for rheumatoid arthritis

ROS Therapeutics™ raises DKK 10 million in seed financing round


ROS Therapeutics today announces the successful closing of a DKK 10.1 mill. seed financing round with participation of founders, advisors, business angels and other private investors.

ROS Therapeutics™ signs patent license agreement


ROS Therapeutics™ signs patent license agreement with the Technical University of Denmark (DTU) regarding molecules for the treatment of inflammatory diseases and cancer

bottom of page